These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3921870)

  • 1. Detection of homovanillic acid in vivo using microcomputer-controlled voltammetry: simultaneous monitoring of rat motor activity and striatal dopamine release.
    O'Neill RD; Fillenz M
    Neuroscience; 1985 Mar; 14(3):753-63. PubMed ID: 3921870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory mechanisms in the substantia nigra and the dopamine pathway.
    Straughan DW; James TA
    Int J Neurol; 1979; 13(1-4):81-93. PubMed ID: 122391
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
    Zhang WQ; Tilson HA; Nanry KP; Hudson PM; Hong JS; Stachowiak MK
    Brain Res; 1988 Oct; 461(2):335-42. PubMed ID: 3141002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats.
    Altar CA; O'Neil S; Marshall JF
    Neuropharmacology; 1984 Mar; 23(3):309-18. PubMed ID: 6427648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian changes in homovanillic acid and ascorbate levels in the rat striatum using microprocessor-controlled voltammetry.
    O'Neill RD; Fillenz M; Albery WJ
    Neurosci Lett; 1982 Dec; 34(2):189-93. PubMed ID: 7183952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional validation of projection topography in the nigrostriatal dopamine system.
    Redgrave P; Mitchell I
    Neuroscience; 1982 Apr; 7(4):885-94. PubMed ID: 6808415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of unilateral cortical lesions on the circadian changes in rat striatal ascorbate and homovanillic acid levels measured in vivo using voltammetry.
    O'Neill RD; Grunewald RA; Fillenz M; Albery WJ
    Neurosci Lett; 1983 Nov; 42(1):105-10. PubMed ID: 6657142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of dopamine release in the denervated striatum.
    Altar CA; Marien MR
    Neurosci Lett; 1989 Jan; 96(3):329-34. PubMed ID: 2497410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of changes in spontaneous motor activity to spontaneous circling in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Carey RJ
    Exp Neurol; 1986 Jun; 92(3):591-600. PubMed ID: 3086112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous monitoring of dopamine release in rat frontal cortex, nucleus accumbens and striatum: effect of drugs, circadian changes and correlations with motor activity.
    O'Neill RD; Fillenz M
    Neuroscience; 1985 Sep; 16(1):49-55. PubMed ID: 3835502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric acid levels and dopamine transmission in rat striatum: diurnal changes and effects of drugs.
    O'Neill RD
    Brain Res; 1990 Jan; 507(2):267-72. PubMed ID: 2337766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis.
    Strecker RE; Sharp T; Brundin P; Zetterström T; Ungerstedt U; Björklund A
    Neuroscience; 1987 Jul; 22(1):169-78. PubMed ID: 2819773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T; Knott P; Kaufmann H; Yahr M
    Adv Neurol; 1990; 53():75-81. PubMed ID: 2173378
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons.
    Kerkerian L; Salin P; Nieoullon A
    Neuroscience; 1988 Sep; 26(3):809-17. PubMed ID: 3143926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term depression in striatal dopamine release monitored by in vivo voltammetry in free moving rats.
    Abraini JH; Raharison L; Rostain JC
    Brain Res; 1991 May; 548(1-2):256-9. PubMed ID: 1678298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dopamine depletion upon the K(+)-evoked release of CCK from superfused striatal slices.
    Sierralta J; Gysling K
    Neurosci Lett; 1990 May; 112(2-3):313-7. PubMed ID: 2113658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.
    Melamed E; Hefti F; Wurtman RJ
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4305-9. PubMed ID: 6254020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intranigral injection of taurine and GABA on striatal dopamine release monitored voltammetrically in the unanaesthetized rat.
    O'Neill RD
    Brain Res; 1986 Sep; 382(1):28-32. PubMed ID: 3768678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.
    Robinson TE; Whishaw IQ
    Brain Res; 1988 May; 450(1-2):209-24. PubMed ID: 3135914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.